Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Carl Martin Philpott 03/03/2014 Katie Jane Voigt 03/03/2014 30 November 2025 no description of principal activity 08920454 2025-03-31 08920454 bus:Director1 2025-03-31 08920454 bus:Director2 2025-03-31 08920454 2024-03-31 08920454 core:CurrentFinancialInstruments 2025-03-31 08920454 core:CurrentFinancialInstruments 2024-03-31 08920454 core:ShareCapital 2025-03-31 08920454 core:ShareCapital 2024-03-31 08920454 core:RetainedEarningsAccumulatedLosses 2025-03-31 08920454 core:RetainedEarningsAccumulatedLosses 2024-03-31 08920454 core:ComputerEquipment 2024-03-31 08920454 core:ComputerEquipment 2025-03-31 08920454 bus:OrdinaryShareClass1 2025-03-31 08920454 2024-04-01 2025-03-31 08920454 bus:FilletedAccounts 2024-04-01 2025-03-31 08920454 bus:SmallEntities 2024-04-01 2025-03-31 08920454 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08920454 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08920454 bus:Director1 2024-04-01 2025-03-31 08920454 bus:Director2 2024-04-01 2025-03-31 08920454 core:ComputerEquipment core:TopRangeValue 2024-04-01 2025-03-31 08920454 2023-04-01 2024-03-31 08920454 core:ComputerEquipment 2024-04-01 2025-03-31 08920454 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 08920454 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 08920454 (England and Wales)

CARL PHILPOTT RHINOLOGY LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

CARL PHILPOTT RHINOLOGY LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

CARL PHILPOTT RHINOLOGY LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
CARL PHILPOTT RHINOLOGY LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 670 980
670 980
Current assets
Debtors 4 39,741 21,538
Cash at bank and in hand 5 6,172 1,274
45,913 22,812
Creditors: amounts falling due within one year 6 ( 22,287) ( 22,584)
Net current assets 23,626 228
Total assets less current liabilities 24,296 1,208
Net assets 24,296 1,208
Capital and reserves
Called-up share capital 7 1,000 1,000
Profit and loss account 23,296 208
Total shareholders' funds 24,296 1,208

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Carl Philpott Rhinology Limited (registered number: 08920454) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Carl Martin Philpott
Director

30 November 2025

CARL PHILPOTT RHINOLOGY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
CARL PHILPOTT RHINOLOGY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Carl Philpott Rhinology Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is High Ash House High Ash Lane, Caistor St. Edmund, Norwich, NR14 8RD, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Computer equipment Total
£ £
Cost
At 01 April 2024 2,604 2,604
At 31 March 2025 2,604 2,604
Accumulated depreciation
At 01 April 2024 1,624 1,624
Charge for the financial year 310 310
At 31 March 2025 1,934 1,934
Net book value
At 31 March 2025 670 670
At 31 March 2024 980 980

4. Debtors

2025 2024
£ £
Trade debtors 6,061 0
Amounts owed by directors 33,420 1,661
Prepayments 260 764
Other debtors 0 19,113
39,741 21,538

5. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 6,172 1,274

6. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 509 977
Accruals 2,952 2,815
Taxation and social security 17,508 18,792
Other creditors 1,318 0
22,287 22,584

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
1,000 Ordinary shares of £ 1.00 each 1,000 1,000